The Government Council, meeting Thursday in Rabat, adopted draft decree No. 2.23.590 relating to the modification of import duties imposed on certain pharmaceutical products.
Presented by the Minister of Health and Social Protection, Khalid Ait Taleb, on behalf of the Minister Delegate to the Minister of Economy and Finance, in charge of the Budget, Fouzi Lekjaa, this text is part of supporting national drug strategies aimed at promoting national industry and facilitating citizens’ access to this type of product, indicated the Minister Delegate to the Head of Government in charge of relations with Parliament, Spokesperson of the government, Mustapha Baitas, during a press briefing after the Council.
In accordance with Article 4 of the 2023 Finance Law, and in coordination with the partners concerned, a restructuring of the tariff of customs duties has been carried out with a view to revising the tariffs of import duties applied to certain finished pharmaceutical products, taking into account the components included in the raw materials used in the manufacture, specified Baitas He also noted that this draft decree aims to avoid any disruption in the supply of the local market, while ensuring the execution of the contracts of contracts concluded by the Department of Health under the best conditions, by reducing the tariffs of import duties imposed on certain pharmaceutical products to 2.5%.
This text, continued Baitas, also aims to modify the import tariff rate applied to other pharmaceutical products, reducing these rates to 2.5% for exclusively imported pharmaceutical products, and to 10% or 17, 5% for products that are both imported and locally produced.